4 completed, 1 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Norgestrel: new trials by email Literature Review of Norgestrel trials Research Report on Norgestrel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level Depo-Provera, Implanon, Norgestrel - Progesterone, Contraceptive Methods | Completed | Tanta University | 80 | 2021-03-30 | 2023-02-24 | |
| Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Norgestrel 0.075 mg tablets - Contraception | Phase 3 | Completed | HRA Pharma | 962 | 2019-09-06 | 2022-05-20 |
| Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill Norgestrel 0.075 mg - Contraception | Phase 2 | Completed | HRA Pharma | 52 | 2018-07-24 | 2021-06-03 |
| A Study of Oral Contraception Under Simulated OTC Conditions Norgestrel 0.075 mg tablets - Contraception | Phase 3 | Terminated | HRA Pharma | 189 | 2018-04-27 | 2022-04-04 |
| Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer medroxyprogesterone, ethinyl estradiol, norgestrel - Endometrial Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 52 | 2002-02-01 | 2013-05-03 |
HRA Pharma (3) · National Cancer Institute (NCI) (1) · Tanta University (1)
United States (4) · Egypt (1)
Alison Edelman, MD (1) · Karen Lu (1) · Mitchell Creinin, MD (1) · Mona K Omar, MD (1) · Russ Bradford, MD, MSPH (1) · Russell Bradford, MD, MSPH (1)